Delivery Order SPE2DB24D2100-SPE2DB24FBCQP
Award Date
7/25/24
Potential Completion Date
7/26/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ORILISSA 150 MG TABLET 7S. The contract, valued at $4,051.04, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 14, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
This federal contract award, valued at $2,251.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,756.28 firm fixed-price delivery order is for the supply of ORILISSA 150 MG TABLET 7S, a prescription medication. The contract has an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $4,806.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product, with an ultimate completion date of October 31, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a Set-Aside contract. Amerisourcebergen Drug Corp, the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,718.59 firm-fixed-price delivery order is for the supply of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract has a period of performance through November 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,888.82, is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. In addition to this specific award,...
This federal contract award, valued at $8,686.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order to provide ORILISSA 150 MG TABLET 7S, a specialty medication. The contract has an ultimate completion date of October 23, 2024 and is a firm fixed-price agreement. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award, valued at $3,715.35, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of September 18, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, a major supplier of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,193.94 firm fixed-price delivery order is for the supply of ORILISSA 150 MG TABLET 7S, a pharmaceutical product, with a period of performance through March 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,235.33 firm fixed-price contract is for the delivery of the drug ORILISSA 150 MG TABLET 7S. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...